These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6886970)

  • 1. The effect of hepatic uptake on the disappearance of warfarin from the plasma of rats: a kinetic analysis.
    Covell DG; Abbrecht PH; Berman M
    J Pharmacokinet Biopharm; 1983 Apr; 11(2):127-45. PubMed ID: 6886970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution pharmacokinetics of warfarin in the rat, a non-linear multicompartment model.
    Kekki M; Julkunen RJ; Wahlström B
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):61-73. PubMed ID: 870833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1975 Oct; 64(10):1660-4. PubMed ID: 1195101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of coumarin anticoagulants XLIV: Dose-dependent pharmacokinetics of warfarin in rats.
    Takada K; Levy G
    J Pharm Sci; 1980 Jan; 69(1):9-14. PubMed ID: 7354452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of the dose-dependent hepatic handling of 1-anilino-8-naphthalene sulfonate in rats.
    Chung YB; Miyauchi S; Sugiyama Y; Harashima H; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1990 Aug; 18(4):313-33. PubMed ID: 2231322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norfloxacin does not alter warfarin's disposition or anticoagulant effect.
    Rocci ML; Vlasses PH; Distlerath LM; Gregg MH; Wheeler SC; Zing W; Bjornsson TD
    J Clin Pharmacol; 1990 Aug; 30(8):728-32. PubMed ID: 2401751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between the dose of warfarin, free drug in plasma, and its elimination in the bile of rats.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):943-50. PubMed ID: 4760900
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of the hepatic transport of organic anions: influence of extra- and intracellular binding on hepatic storage of dibromosulfophthalein and interactions with indocyanine green.
    Meijer DK; Blom A; Weitering JG; Hornsveld R
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):43-65. PubMed ID: 6747818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of coumarin anticoagulants XLIII: Concentration-dependent hepatic uptake of warfarin in rats.
    Takada K; Levy G
    J Pharm Sci; 1979 Dec; 68(12):1569-71. PubMed ID: 529059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonlinear pharmacokinetics of hepatobiliary transport of rose bengal in rats after i.v. bolus administration with varying doses.
    Wang HK; Miyachi S; Yamazaki M; Sawada Y; Chung YB; Iga T; Hanano M; Sugiyama Y
    Biopharm Drug Dispos; 1992 Dec; 13(9):647-62. PubMed ID: 1467452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of erythromycin on the disposition kinetics of warfarin.
    Bachmann K; Schwartz JI; Forney R; Frogameni A; Jauregui LE
    Pharmacology; 1984; 28(3):171-6. PubMed ID: 6718483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent pharmacokinetics of warfarin in healthy volunteers.
    King SY; Joslin MA; Raudibaugh K; Pieniaszek HJ; Benedek IH
    Pharm Res; 1995 Dec; 12(12):1874-7. PubMed ID: 8786959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin resistance with nafcillin therapy.
    Qureshi GD; Reinders TP; Somori GJ; Evans HJ
    Ann Intern Med; 1984 Apr; 100(4):527-9. PubMed ID: 6703546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
    Imawaka H; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent pharmacokinetics and biliary excretion of bromophenol blue in the rat.
    Wills RJ; Smith RB; Yakatan GJ
    J Pharm Sci; 1983 Oct; 72(10):1127-31. PubMed ID: 6644556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and warfarin disposition.
    Bachmann K; Shapiro R; Fulton R; Carroll FT; Sullivan TJ
    Clin Pharmacol Ther; 1979 Mar; 25(3):309-15. PubMed ID: 761442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liver.
    Tsao SC; Sugiyama Y; Sawada Y; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1988 Apr; 16(2):165-81. PubMed ID: 3418494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic study on saturated hepato-biliary transport of acetyl procainamide ethobromide.
    Nakae H; Muranishi S; Asada S; Takada K
    J Pharmacobiodyn; 1981 Aug; 4(8):584-9. PubMed ID: 6170747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of albumin on hepatic uptake of warfarin in normal and analbuminemic mutant rats: analysis by multiple indicator dilution method.
    Tsao SC; Sugiyama Y; Sawada Y; Nagase S; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1986 Feb; 14(1):51-64. PubMed ID: 3746632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.